FDA Authorizes First Digital Therapeutic for Migraine
The US Food and Drug Administration (FDA) has granted marketing authorization to CT-132 (Click Therapeutics), an adjunctive, first-in-class…
Largest Genome-Wide Association Study Uncovers New Drug Targets and Potential Therapies for Osteoarthritis
April 15, 2025 | Deborah Kotz Newswise — About one in five American adults have osteoarthritis, the most common form…